U.S. pharma huge copyright scrapped two experimental weight loss drugs very last 12 months—a at the time-daily capsule, lotiglipron, on account of elevated liver enzymes along with a twice-daily capsule, danuglipron, on account of strong Unintended effects—but CEO Albert Bourla has said the company is set to “Perform and earn” inside the ob